TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260409. A total of 23 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DIALECTIC CAPITAL MANAGEMENT, LP | 40,000 | $187,000 | 0.12% |
| DAFNA Capital Management LLC | 20,000 | $93,000 | 0.08% |
| Baker Brothers Advisors | 449,500 | $2,099,000 | 0.02% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 10,166 | $47,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 2,300 | $11,000 | 0.00% |
| GLENMEDE TRUST CO NA | 100 | $0 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 14,121 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 200 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 200 | $1,000 | 0.00% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 102 | $0 | 0.00% |